NTLA icon

Intellia Therapeutics

363 hedge funds and large institutions have $8.34B invested in Intellia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 130 increasing their positions, 113 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more call options, than puts

Call options by funds: $ | Put options by funds: $

6.79% less ownership

Funds ownership: 91.42%84.63% (-6.8%)

17% less capital invested

Capital invested by funds: $10B → $8.34B (-$1.68B)

33% less funds holding in top 10

Funds holding in top 10: 128 (-4)

Holders
363
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$99.9M
Puts
$94M
Net Calls
Net Calls Change

Top Buyers

1 +$79.1M
2 +$75.9M
3 +$60.6M
4
Morgan Stanley
Morgan Stanley
New York
+$60.1M
5
Victory Capital Management
Victory Capital Management
Texas
+$50.4M

Top Sellers

1 -$149M
2 -$126M
3 -$97.6M
4
NAMA
Nikko Asset Management Americas
New York
-$89.1M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$54M
Name Holding Trade Value Shares
Change
Change in
Stake
326
$28K
327
$23K
328
$22K
329
$21K
330
$19.7K
331
$19K
332
$18K
333
$18K
334
$16.4K
335
$13K
336
$13K
337
$12K
338
$11K
339
$9K
340
$9K
341
$9K
342
$8K
343
$6K
344
$6K
345
$5K
346
$5K
347
$3.55K
348
$3K
349
$3K
350
$3K